Extremely Rare Opportunity for a Business of this Quality
– Price at 4.7 Times EBITDA
– Specialty Comps Range from 5.5X – 13.5X
– Mean – 9.7X
– $243 Billion U.S. Market.
– $1.3 Trillion U.S. Market Estimate 2033.
– Prime So Cal Location in Proximity to Prestigious Hospitals and Major Medical Center.
– Rheumatology, Immunization & Pain Management Specialization.
– Immunization, Compounds of all Formats Including Children.
– Pain Medications in Differing Dosage Forms.
– Award Winning Pain Management Initiatives.
– Patient involvement with Insurance Companies for Financial Relief.
